These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11549836)

  • 1. Advantage of expressing the variations in some digestive parameters as a function of gastric emptying instead of time.
    Carrière F; Renou C; Ville E; Grandval P; Laugier R
    Digestion; 2001; 64(1):46-53. PubMed ID: 11549836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lansoprazole on human gastric lipase secretion and intragastric lipolysis in healthy human volunteers.
    Renou C; Carrière F; Ville E; Grandval P; Joubert-Collin M; Laugier R
    Digestion; 2001; 63(4):207-13. PubMed ID: 11435719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals.
    Carrière F; Renou C; Lopez V; De Caro J; Ferrato F; Lengsfeld H; De Caro A; Laugier R; Verger R
    Gastroenterology; 2000 Oct; 119(4):949-60. PubMed ID: 11040182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does lansoprazole influence postprandial digestive function?
    Vidon N; Dutreuil C; Scoule JC; Delchier JC
    Aliment Pharmacol Ther; 1993 Dec; 7(6):629-34. PubMed ID: 8161669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological study of pH stability and sensitivity to pepsin of human gastric lipase.
    Ville E; Carrière F; Renou C; Laugier R
    Digestion; 2002; 65(2):73-81. PubMed ID: 12021480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of CYP2C19 and gastric emptying in patients with proton pump inhibitor-resistant gastric ulcers.
    Wada F; Murase K; Isomoto H; Soda H; Takeshima F; Omagari K; Mizuta Y; Tsukamoto K; Murata I; Kohno S
    J Int Med Res; 2002; 30(4):413-21. PubMed ID: 12235924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid-suppressive effects of rabeprazole, omeprazole, and lansoprazole at reduced and standard doses: a crossover comparative study in homozygous extensive metabolizers of cytochrome P450 2C19.
    Shimatani T; Inoue M; Kuroiwa T; Xu J; Mieno H; Nakamura M; Tazuma S
    Clin Pharmacol Ther; 2006 Jan; 79(1):144-52. PubMed ID: 16413249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation into the role of cephalic stimulation of acid secretion on gastric emptying and appetite following a soup meal using the gastric acid inhibitor omeprazole.
    Cecil JE; Francis J; Read NW
    Appetite; 2004 Feb; 42(1):99-105. PubMed ID: 15036788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative study of digestive enzyme secretion and gastrointestinal lipolysis in chronic pancreatitis.
    Carrière F; Grandval P; Renou C; Palomba A; Priéri F; Giallo J; Henniges F; Sander-Struckmeier S; Laugier R
    Clin Gastroenterol Hepatol; 2005 Jan; 3(1):28-38. PubMed ID: 15645402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod.
    Tougas G; Earnest DL; Chen Y; Vanderkoy C; Rojavin M
    Aliment Pharmacol Ther; 2005 Jul; 22(1):59-65. PubMed ID: 15963081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual effects of rabeprazole on solid-phase gastric emptying assessed by the 13C-octanoate breath test.
    Anjiki H; Sanaka M; Kuyama Y
    Digestion; 2005; 72(2-3):189-94. PubMed ID: 16179787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.
    Natale G; Lazzeri G; Lubrano V; Colucci R; Vassalle C; Fornai M; Blandizzi C; Del Tacca M
    Toxicol Appl Pharmacol; 2004 Feb; 195(1):62-72. PubMed ID: 14962506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplified lansoprazole suspension--a liquid formulation of lansoprazole--effectively suppresses intragastric acidity when administered through a gastrostomy.
    Sharma VK; Vasudeva R; Howden CW
    Am J Gastroenterol; 1999 Jul; 94(7):1813-7. PubMed ID: 10406240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.
    Freston J; Chiu YL; Pan WJ; Lukasik N; Täubel J
    Am J Gastroenterol; 2001 Jul; 96(7):2058-65. PubMed ID: 11467632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevant pH and lipase for in vitro models of gastric digestion.
    Sams L; Paume J; Giallo J; Carrière F
    Food Funct; 2016 Jan; 7(1):30-45. PubMed ID: 26527368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the pharmacokinetics and pharmacodynamics of intravenous lansoprazole.
    Freston JW; Pilmer BL; Chiu YL; Wang Q; Stolle JC; Griffin JS; Lee CQ
    Aliment Pharmacol Ther; 2004 May; 19(10):1111-22. PubMed ID: 15142201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J; Laskowiec G
    Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.
    Furuta T; Shirai N; Sugimoto M; Nakamura A; Okudaira K; Kajimura M; Hishida A
    Aliment Pharmacol Ther; 2005 Jul; 22(1):67-74. PubMed ID: 15963082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.